252 related articles for article (PubMed ID: 14974293)
1. [Transvaginal bleeding in pregnancy, as risk factor of Rhesus-D antigen isoimmunization].
Hernández-Andrade E; Ahued-Ahued JR
Salud Publica Mex; 2003; 45(6):492-6. PubMed ID: 14974293
[TBL] [Abstract][Full Text] [Related]
2. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
3. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
[TBL] [Abstract][Full Text] [Related]
4. Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
Boulet S; Krause C; Tixier H; Bardou M; Sagot P
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):65-70. PubMed ID: 19482403
[TBL] [Abstract][Full Text] [Related]
5. [Factors associated with acceptance of postpartum tubal ligation among HIV-infected women].
Figueroa-Damián R; Villagrana-Zesati R
Salud Publica Mex; 2001; 43(2):97-102. PubMed ID: 11381847
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
7. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
[No Abstract] [Full Text] [Related]
8. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
9. [Advantages of preventing Rh isoimmunization].
Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
[TBL] [Abstract][Full Text] [Related]
10. Antenatal prophylaxis of Rh isoimmunization: 28-weeks'-gestation service program.
Bowman JM; Pollock JM
Can Med Assoc J; 1978 Mar; 118(6):627-30. PubMed ID: 77715
[TBL] [Abstract][Full Text] [Related]
11. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
12. [Decreasing Rhesus serum antibody titer in pregnancy with Rhesus constellation].
Kölbl H; Riss P
Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):285-6. PubMed ID: 3110000
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
Tuohy JF; Sangalli M; Kim L
Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
[TBL] [Abstract][Full Text] [Related]
14. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
[TBL] [Abstract][Full Text] [Related]
15. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
[TBL] [Abstract][Full Text] [Related]
16. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
17. [Immunohematological surveillance of the pregnant woman: new prevention policy].
Mannessier L
Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
[TBL] [Abstract][Full Text] [Related]
18. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.
Weinberg L
Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491
[TBL] [Abstract][Full Text] [Related]
19. The pregnant Rhesus negative Nigerian woman.
Kotila TR; Odukogbe AA; Okunlola MA; Olayemi O; Obisesan KA
Niger Postgrad Med J; 2005 Dec; 12(4):305-7. PubMed ID: 16380744
[TBL] [Abstract][Full Text] [Related]
20. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
Mannessier L
Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
